JP Morgan Chase & Co’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.21M | Sell |
|
|||||
|
2025
Q2 | $4.06M | Sell |
|
|||||
|
2025
Q1 | $9.27M | Buy |
|
|||||
|
2024
Q4 | $13.1M | Sell |
|
|||||
|
2024
Q3 | $112M | Buy |
|
|||||
|
2024
Q2 | $122M | Buy |
|
|||||
|
2024
Q1 | $130M | Sell |
|
|||||
|
2023
Q4 | $154M | Buy |
|
|||||
|
2023
Q3 | $84.4M | Buy |
|
|||||
|
2023
Q2 | $163M | Buy |
|
|||||
|
2023
Q1 | $109M | Sell |
|
|||||
|
2022
Q4 | $95.5M | Buy |
|
|||||
|
2022
Q3 | $64.2M | Sell |
|
|||||
|
2022
Q2 | $48.6M | Sell |
|
|||||
|
2022
Q1 | $64.3M | Sell |
|
|||||
|
2021
Q4 | $75.1M | Buy |
|
|||||
|
2021
Q3 | $50.5M | Buy |
|
|||||
|
2021
Q2 | $26.2M | Sell |
|
|||||
|
2021
Q1 | $18.7M | Sell |
|
|||||
|
2020
Q4 | $36.1M | Sell |
|
|||||
|
2020
Q3 | $20.3M | Buy |
|
|||||
|
2020
Q2 | $3.3M | Buy |
|
|||||
|
2020
Q1 | $2.06M | Sell |
|
|||||
|
2019
Q4 | $13.1M | Buy |
|
|||||
|
2019
Q3 | $382K | Buy |
|
|||||
|
2019
Q2 | $325K | Buy |
|
|||||
|
2019
Q1 | $172K | Sell |
|
|||||
|
2018
Q4 | $122K | Buy |
|
|||||
|
2018
Q3 | $149K | Sell |
|
|||||
|
2018
Q2 | $1.23M | Buy |
|
|||||
|
2018
Q1 | $49K | Sell |
|
|||||
|
2017
Q4 | $51K | Buy |
|